毛霉菌感染的治疗进展

Recent progresses in the treatment of mucormycosis

毛霉菌病（Mucormycosis）是一种危及生命的侵袭性真菌感染。其通常发生在糖尿病患者、器官或造血干细胞移植受体、中性粒细胞减少症患者及恶性肿瘤患者中。近来，毛霉菌病的发生率有所增加，成为抗感染领域新近的研究热点。现就近年来毛霉菌感染治疗方面的进展做一综述。

Mucormycosis is a life - threatening invasive fungal infection typically occurs in patients with diabetes mellitus, patients who have received organ or hematopoietic stem cell transplant （ HSCT）, patients with neutropenia,or patients with malignancy. Recently the morbidity of such disease have increased, and it becomes a hot spot of infection disease treatment. Now we review its advances in treatment of recent years.